From: The Eag potassium channel as a new prognostic marker in ovarian cancer
Age at diagnosis, years, median (IQR) | 62 (24-90) |
---|---|
Overall survival, months, median (IQR) | 19.5 (0-271) |
FIGO Stage | n (%) |
1 | 84 (25.0) |
2 | 36 (10.7) |
3 | 166 (49.4) |
4 | 40 (11.9) |
Missing | 10 (3.0) |
Grade | n (%) |
G1 | 39 (11.6) |
G2 | 73 (21.7) |
G3 | 221 (65.8) |
Missing | 3 (0.9) |
Residual disease | n (%) |
No macroscopic disease (Optimal debulking) | 128 (38.1) |
Macroscopic disease left | 194 (57.7) |
Missing | 14 (4.2) |
Histological type | n (%) |
Serous | 178 (53) |
Mucinous | 35 (10.4) |
Endometriod | 42 (12.5) |
Clear cell | 25 (7.4) |
Undifferentiated | 54 (16.1) |
Missing | 2 (0.6) |
Chemotherapy | n (%) |
Yes | 236 (70.2) |
No | 92 (27.4) |
Missing | 8 (2.4) |
Eag staining | n (%) |
Low/Intermediate | 196 (58.3) |
High | 53 (15.8) |
Missing | 87 (25.9) |
HERG staining | n (%) |
Low/Intermediate | 181 (53.9) |
High | 68 (20.2) |
Missing | 87 (25.9) |